Skip to main content
. 2017 Oct 12;135(10):1037–1044. doi: 10.1001/jamaophthalmol.2017.3195

Table 2. Phenotypical Characteristics of Carriers and Noncarriers of Rare CFH Variants.

Phenotypic Characteristic No. of Eyes (%) Odds Ratio (95% CI)a P Value
Noncarrier
(n = 204)
Carrier
(n = 100)
Predominant drusen type within ETDRS grid
None or small drusen (<63 µm) 32 (15.7) 12 (12.0) 1 [Reference] .31
Intermediate drusen (63-125 µm) 107 (52.5) 45 (45.0) 1.12 (0.47-2.68)
Large drusen (>125 µm) 65 (31.9) 43 (43.0) 1.76 (0.71-4.38)
Largest drusen type within central field
None or small drusen (<63 µm) 106 (52.5) 44 (44.9) 1 [Reference] .58
Intermediate drusen (63-125 µm) 77 (38.1) 44 (44.9) 1.38 (0.75-2.52)
Large drusen (>125 µm) 19 (9.4) 10 (10.2) 1.27 (0.46-3.48)
Proportion of grid area covered by drusen, %
0-10 111 (54.4) 27 (27.3) 1 [Reference] .004b
10-25 61 (29.9) 41 (41.4) 2.76 (1.36-5.63)
25-50 29 (14.2) 26 (26.3) 3.69 (1.58-8.58)
>50 3 (1.5) 5 (5.1) 6.85 (1.37-34.37)
Extramacular drusen
Absent 54 (26.6) 19 (19.2) 1 [Reference] .27
Present 149 (73.4) 80 (80.8) 1.53 (0.72-3.24)
Drusen nasal to the optic disc
None or small drusen (<63 µm) 89 (65.0) 45 (56.3) 1 [Reference] .47
Intermediate drusen (63-125 µm) 46 (33.6) 32 (40.0) 1.38 (0.69-2.74)
Large drusen (>125 µm) 2 (1.5) 3 (3.8) 2.97 (0.30-29.51)
Reticular drusen
Absent 163 (86.7) 83 (93.3) 1 [Reference] .14
Present 25 (13.3) 6 (6.7) 0.47 (0.18-1.27)
Drusen with crystalline appearance
Absent 178 (89.4) 76 (81.7) 1 [Reference] .15
Present 21 (10.6) 17 (18.3) 1.90 (0.80-4.48)
SPED
Absent 199 (97.5) 84 (89.4) 1 [Reference] .02
Present 5 (2.5) 10 (10.6) 4.74 (1.30-17.31)
RPE pigmentation
Absent 84 (45.4) 31 (32.3) 1 [Reference] .08
Present 101 (54.6) 65 (67.7) 1.74 (0.93-3.27)
Geographic atrophy
Absent 154 (76.2) 65 (70.7) 1 [Reference] .42
Present 48 (23.8) 27 (29.3) 1.33 (0.66-2.69)
Neovascular AMD
Absent 144 (72.4) 79 (82.3) 1 [Reference] .12
Present 55 (27.6) 17 (17.7) 0.56 (0.28-1.15)

Abbreviations: AMD, age-related macular degeneration; CFH, complement factor H; ETDRS, Early Treatment Diabetic Retinopathy Study; RPE, retinal pigment epithelium; SPED, serogranular/serous drusen pigment epithelium detachment.

a

The presented odds ratios result from univariable generalized estimating equations logistic regression analyses.

b

P value remained significant after Bonferroni correction for multiple testing.